|
|
||||||||

,
,
Departments of
*
Laboratory Medicine and
Medicine, University of Washington, Seattle, WA 98195; and
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
Herpes simplex virus (HSV) establishes a lifelong infection in humans. Reactivation of latent virus occurs intermittently so that the immune system is frequently exposed to viral Ag, providing an opportunity to evaluate memory T cells to a persistent human pathogen. We studied the persistence of genital herpes lesion-derived HSV-specific CD8+ CTL from three immunocompetent individuals with frequently recurring genital HSV-2 infection. All CTL clones were HSV-2 type specific and only one to three unique clonotypes were identified from any single biopsy specimen. The TCRBV genes utilized by these clonotypes were sequenced, and clonotype-specific probes were used to longitudinally track these clonotypes in PBMC and genital lesions. CTL clonotypes were consistently detected in PBMC and lesions for at least 2 and up to 7 years, and identical clonotypes infiltrated herpes lesions spaced as long as 7.5 years apart. Moreover, these clones were functionally lytic in vivo over these time periods. Additionally, CTL clones killed target cells infected with autologous viral isolates obtained 6.5 years after CTL clones were established, suggesting that selective pressure by these CTL did not result in the mutation of CTL epitopes. Thus, HSV recurs in the face of persistent CD8+ CTL with no evidence of clonal exhaustion or mutation of CTL epitopes as mechanisms of viral persistence.
This article has been cited by other articles:
![]() |
L. Derre, M. Bruyninx, P. Baumgaertner, E. Devevre, P. Corthesy, C. Touvrey, Y. D. Mahnke, H. Pircher, V. Voelter, P. Romero, et al. In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration J. Immunol., August 15, 2007; 179(4): 2368 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thapa, W. A. Kuziel, and D. J. J. Carr Susceptibility of CCR5-Deficient Mice to Genital Herpes Simplex Virus Type 2 Is Linked to NK Cell Mobilization J. Virol., April 15, 2007; 81(8): 3704 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Speiser, P. Baumgaertner, C. Barbey, V. Rubio-Godoy, A. Moulin, P. Corthesy, E. Devevre, P.-Y. Dietrich, D. Rimoldi, D. Lienard, et al. A Novel Approach to Characterize Clonality and Differentiation of Human Melanoma-Specific T Cell Responses: Spontaneous Priming and Efficient Boosting by Vaccination J. Immunol., July 15, 2006; 177(2): 1338 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Fernandez-Real, A. Lopez-Bermejo, J. Vendrell, M.-J. Ferri, M. Recasens, and W. Ricart Burden of Infection and Insulin Resistance in Healthy Middle-Aged Men Diabetes Care, May 1, 2006; 29(5): 1058 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Koelle, J. Huang, M. T. Hensel, and C. L. McClurkan Innate Immune Responses to Herpes Simplex Virus Type 2 Influence Skin Homing Molecule Expression by Memory CD4+ Lymphocytes J. Virol., March 15, 2006; 80(6): 2863 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bosnjak, M. Miranda-Saksena, D. M. Koelle, R. A. Boadle, C. A. Jones, and A. L. Cunningham Herpes Simplex Virus Infection of Human Dendritic Cells Induces Apoptosis and Allows Cross-Presentation via Uninfected Dendritic Cells J. Immunol., February 15, 2005; 174(4): 2220 - 2227. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Brainard, W. G. Tharp, E. Granado, N. Miller, A. K. Trocha, X.-H. Ren, B. Conrad, E. F. Terwilliger, R. Wyatt, B. D. Walker, et al. Migration of Antigen-Specific T Cells Away from CXCR4-Binding Human Immunodeficiency Virus Type 1 gp120 J. Virol., May 15, 2004; 78(10): 5184 - 5193. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Koelle and L. Corey Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Langelier, S. Bergeron, S. Chabaud, J. Lippens, C. Guilbault, A. M.-J. Sasseville, S. Denis, D. D. Mosser, and B. Massie The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation J. Gen. Virol., November 1, 2002; 83(11): 2779 - 2789. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gierynska, U. Kumaraguru, S.-K. Eo, S. Lee, A. Krieg, and B. T. Rouse Induction of CD8 T-Cell-Specific Systemic and Mucosal Immunity against Herpes Simplex Virus with CpG-Peptide Complexes J. Virol., June 5, 2002; 76(13): 6568 - 6576. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Langston, I. Redei, A. M. Caliendo, J. Somani, D. Hutcherson, S. Lonial, S. Bucur, J. Cherry, A. Allen, and E. K. Waller Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation Blood, February 1, 2002; 99(3): 1085 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mikloska, L. Bosnjak, and A. L. Cunningham Immature Monocyte-Derived Dendritic Cells Are Productively Infected with Herpes Simplex Virus Type 1 J. Virol., July 1, 2001; 75(13): 5958 - 5964. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Harandi, B. Svennerholm, J. Holmgren, and K. Eriksson Differential roles of B cells and IFN-{{gamma}}-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice J. Gen. Virol., April 1, 2001; 82(4): 845 - 853. [Abstract] [Full Text] |
||||
![]() |
D. M. Koelle, H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells J. Immunol., March 15, 2001; 166(6): 4049 - 4058. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |